Major and potential prothrombotic genotypes in patients with venous thrombosis and in healthy subjects from Slovenia

Pathophysiology of Haemostasis and Thrombosis

Volumn 36, Issue 2, 2008, Pages 58-63

  Bedenčič, Mateja ^a   Božič, Mojca ^a   Peternel, Polona ^a   Stegnar, Mojca ^a  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

Author keywords

Genetic predisposition to disease; Polymorphism; Venous thrombosis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); BLOOD CLOTTING FACTOR 12; BLOOD CLOTTING FACTOR 5 LEIDEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DNA POLYMORPHISM; GENE FREQUENCY; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RECURRENT DISEASE; SLOVENIA; VEIN THROMBOSIS;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FACTOR V; FACTOR XII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; MUTATION; PLASMINOGEN ACTIVATOR INHIBITOR 1; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTHROMBIN; RECURRENCE; RISK; SLOVENIA; THROMBOPHILIA; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 58549101126     PISSN: 14248832     EISSN: None     Source Type: Journal    
DOI: 10.1159/000173722     Document Type: Article

References (38)

1. Franco RF, Reitsma PH: Genetic risk factors of venous thrombosis. Hum Genet 2001;109:369-384.
2. Zoller B, Garcia de Frutos P, Hillarp A, Dahlback B: Thrombophilia as a multigenic disease. Haematologica 1999;84:59-70.
3. Bosler D, Mattson J, Crisan D: Phenotypic heterogeneity in patients with homozygous prothrombin 20210AA genotype: a paper from the 2005 William Beaumont Hospital Symposium on Molecular Pathology. J Mol Diagn 2006;8:420-425.
4. Den Heijer M, Lewington S, Clarke R: Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemost 2005;3:292-299.
5. Den Heijer M, Rosendaal FR, Blom HJ, Gerrits WB, Bos GM: Hyperhomocysteinemia and venous thrombosis: a meta-analysis. Thromb Haemost 1998;80:874-877.
6. Sartori MT, Wiman B, Vettore S, Dazzi F, Girolami A, Patrassi GM: 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis. Thromb Haemost 1998;80:956-960.
7. Ossei-Gerning N, Mansfield MW, Stickland MH, Wilson IJ, Grant PJ: Plasminogen activator inhibitor-1 promoter 4G/5G genotype and plasma levels in relation to a history of myocardial infarction in patients characterized by coronary angiography. Arterioscler Thromb Vasc Biol 1997;17:33-37.
8. Francis CW: Plasminogen activator inhibitor-1 levels and polymorphisms. Arch Pathol Lab Med 2002;126:1401-1404.
9. Pihusch M: Plasminogen activator inhibitor-1: a review. J Lab Med 2005;29:403-411.
10. Segui R, Estelles A, Mira Y, Espana F, Villa P, Falco C, Vaya A, Grancha S, Ferrando F, Aznar J: PAI-1 promoter 4G/5G genotype as an additional risk factor for venous thrombosis in subjects with genetic thrombophilic defects. Br J Haematol 2000;111:122-128.
11. Stegnar M, Uhrin P, Peternel P, Mavri A, Salobir-Pajnic B, Stare J, Binder BR: The 4G/5G sequence polymorphism in the promoter of plasminogen activator inhibitor-1 (PAI-1) gene: relationship to plasma PAI-1 level in venous thromboembolism. Thromb Haemost 1998;79:975-979.
12. Tirado I, Soria JM, Mateo J, Oliver A, Souto JC, Santamaria A, Felices R, Borrell M, Fontcuberta J: Association after linkage analysis indicates that homozygosity for the 46C->T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004;91:899-904.
13. Grunbacher G, Marx-Neuhold E, Pilger E, Koppel H, Renner W: The functional -4C>T polymorphism of the coagulation factor XII gene is not associated with deep venous thrombosis. J Thromb Haemost 2005;3:2815-2817.
14. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, Niho Y: A common genetic polymorphism (46 C to T substitution) in the 5′-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998;91:2010-2014.
15. Bertina RM, Poort SR, Vos HL, Rosendaal FR: The 46C->T polymorphism in the factor XII gene (F12) and the risk of venous thrombosis. J Thromb Haemost 2005;3:597-599.
16. Rees DC, Cox M, Clegg JB: World distribution of factor V Leiden. Lancet 1995;346:1133-1134.
17. Rosendaal FR, Doggen CJ, Zivelin A, Arruda VR, Aiach M, Siscovick DS, Hillarp A, Watzke HH, Bernardi F, Cumming AM, Preston FE, Reitsma PH: Geographic distribution of the 20210 G to A prothrombin variant. Thromb Haemost 1998;79:706-708.
18. Bottiger C, Koch W, Lahn C, Mehilli J, von Beckerath N, Schomig A, Kastrati A: 4G/5G polymorphism of the plasminogen activator inhibitor-1 gene and risk of restenosis after coronary artery stenting. Am Heart J 2003;146:855-861.
19. Coen D, Zadro R, Honovic L, Banfic L, Stavljenic Rukavina A: Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism. Croat Med J 2001;42:488-492.
20. Cattaneo M, Chantarangkul V, Taioli E, Santos JH, Tagliabue L: The G20210A mutation of the prothrombin gene in patients with previous first episodes of deep-vein thrombosis: prevalence and association with factor V G1691A, methylenetetrahydrofolate reductase C677T and plasma prothrombin levels. Thromb Res 1999;93:1-8.
21. Renner W, Koppel H, Hoffmann C, Schallmoser K, Stanger O, Toplak H, Wascher TC, Pilger E: Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res 2000;99:35-39.
22. Margaglione M, D'Andrea G, d'Addedda M, Giuliani N, Cappucci G, Iannaccone L, Vecchione G, Grandone E, Brancaccio V, Di Minno G: The methylenetetrahydrofolate reductase TT677 genotype is associated with venous thrombosis independently of the coexistence of the FV Leiden and the prothrombin A20210 mutation. Thromb Haemost 1998;79:907-911.
23. Stegnar M, Peternel P, Uhrin P, Cvelbar-Marinko T, Goršič- Tomažič K, Binder BR: Fibrinolysis in patients with the 1691 G->A mutation in factor V gene and history of deep vein thrombosis. Fibrinolys Proteolys 1997;11:201-207.
24. Meglic L, Stegnar M, Milanez T, Bozic M, Peterlin B, Peternel P, Novak-Antolic Z: Factor V Leiden, prothrombin 20210G ->A, methylenetetrahydrofolate reductase 677C->T and plasminogen activator inhibitor 4G/5G polymorphism in women with pregnancy-related venous thromboembolism. Eur J Obstet Gynecol Reprod Biol 2003;111:157-163.
25. Lowe GD: Venous and arterial thrombosis: epidemiology and risk factors at various ages. Maturitas 2004;47:259-263.
26. Poort SR, Rosendaal FR, Reitsma PH, Bertina RM: A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-3703.
27. Zuntar I, Topic E, Vukosavic D, Vukovic V, Demarin V, Begonja A, Antoljak N, Simundic AM: Croatian population data for the C677T polymorphism in methylenetetrahydrofolate reductase: frequencies in healthy and atherosclerotic study groups. Clin Chim Acta 2003;335:95-100.
28. Seinost G, Renner W, Brodmann M, Winkler M, Koppel H, Pilger E: C677T mutation in the methylene tetrahydrofolate reductase gene as a risk factor for venous thrombotic disease in Austrian patients. Thromb Res 2000;100:405-407.
29. Bezemer ID, Doggen CJ, Vos HL, Rosendaal FR: No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med 2007;167:497-501.
30. D'Angelo A, Mazzola G, Fermo I: Gene-gene and gene-environment interactions in mild hyperhomocysteinemia. Pathophysiol Haemost Thromb 2003/2004;33:337-341.
31. Herrmann W, Schorr H, Bodis M, Knapp JP, Muller A, Stein G, Geisel J: Role of homocysteine, cystathionine and methylmalonic acid measurement for diagnosis of vitamin deficiency in high-aged subjects. Eur J Clin Invest 2000;30:1083-1089.
32. Barcellona D, Fenu L, Cauli C, Pisu G, Marongiu F: Allele 4G of gene PAI-1 associated with prothrombin mutation G20210A increases the risk for venous thrombosis. Thromb Haemost 2003;90:1061-1064.
33. Varela ML, Adamczuk YP, Forastiero RR, Martinuzzo ME, Cerrato GS, Pombo G, Carreras LO: Major and potential prothrombotic genotypes in a cohort of patients with venous thromboembolism. Thromb Res 2001;104:317-324.
34. Tsantes AE, Nikolopoulos GK, Bagos PG, Rapti E, Mantzios G, Kapsimali V, Travlou A: Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and venous thrombosis: a meta-analysis. Thromb Haemost 2007;97:607-613.
35. Endler G, Exner M, Mannhalter C, Meier S, Ruzicka K, Handler S, Panzer S, Wagner O, Quehenberger P: A common C->T polymorphism at nt 46 in the promoter region of coagulation factor XII is associated with decreased factor XII activity. Thromb Res 2001;101:255-260.
36. Franco RF, Reitsma PH, Lourenco D, Maffei FH, Morelli V, Tavella MH, Araujo AG, Piccinato CE, Zago MA: Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis. Thromb Haemost 1999;81:676-679.
37. Cochery-Nouvellon E, Mercier E, Lissalde-Lavigne G, Daures JP, Quere I, Dauzat M, Mares P, Gris JC: Homozygosity for the C46T polymorphism of the F12 gene is a risk factor for venous thrombosis during the first pregnancy. J Thromb Haemost 2007;5:700-707.
38. Souto JC, Almasy L, Borrell M, Blanco-Vaca F, Mateo J, Soria JM, Coll I, Felices R, Stone W, Fontcuberta J, Blangero J: Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet 2000;67:1452-1459.